GENEVA, July 1 -- CARDIO DIAGNOSTICS, INC. filed a patent application (US2025/059540) for “PREDICTING MORTALITY FROM BIOLOGICAL DATA”. With publication no. WO/2026/128886, here are the other details r... Read More
GENEVA, July 1 -- 1ST AVENUE NOVA, LLC filed a patent application (US2025/059648) for “NATUREMOUNT SOLAR ARRAYS”. With publication no. WO/2026/128901, here are the other details related to the patent ... Read More
GENEVA, July 1 -- 2PI INC. filed a patent application (US2025/059733) for “MULTI-ZONE FLAT-OPTICS ARCHITECTURES, SYSTEMS AND METHODS”. With publication no. WO/2026/128917, here are the other details r... Read More
GENEVA, July 1 -- JIO PLATFORMS LIMITED filed a patent application (IN2024/051006) for “METHOD AND SYSTEM FOR HANDLING ERRORS BETWEEN A HOME NETWORK AND A FOREIGN NETWORK”. With publication no. WO/202... Read More
GENEVA, July 1 -- NANA, Rahul S. filed a patent application (US2025/059459) for “SYSTEMS AND METHODS FOR HARNESSING THERMAL GRADIENT ENERGY”. With publication no. WO/2026/128841, here are the other de... Read More
GENEVA, July 1 -- UNIVERSITY OF WYOMING filed a patent application (US2025/059521) for “COMPOSITIONS AND METHODS FOR STABILIZING RIBONUCLEIC ACID IN THE DRY STATE”. With publication no. WO/2026/128880... Read More
GENEVA, July 1 -- SERES THERAPEUTICS, INC. filed a patent application (US2025/059532) for “BIOMARKERS FOR THE TREATMENT OF BLOODSTREAM INFECTIONS AND GASTROINTESTINAL DISEASES”. With publication no. W... Read More
GENEVA, July 1 -- SCENARIO TRAINER INC. filed a patent application (US2025/059422) for “EXPLOSIVE DEVICE SIMULATOR”. With publication no. WO/2026/128822, here are the other details related to the pate... Read More
GENEVA, July 1 -- UNIVERSITY OF UTAH RESEARCH FOUNDATION filed a patent application (US2025/059434) for “POLYGLUTAMIC ACIDS AS POTENT ANTIFREEZE MOLECULES”. With publication no. WO/2026/128828, here a... Read More
GENEVA, July 1 -- REMIX THERAPEUTICS INC. filed a patent application (US2025/059444) for “COMPOUNDS AND RELATED METHODS USEFUL FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES”. ... Read More